Pharma pledges support for healthcare reform efforts, but warns against price controls
After years of disagreement with Democrats, the pharmaceutical industry's top lobbyist said he is ready to work with the party as it assumes power to expand healthcare coverage. The remarks by Billy Tauzin, head of the Pharmaceutical Research and Manufacturers of America, appeared to signal that the industry plans to defend its interests amid what's likely to be the strongest push for health reform yet. But even as Tauzin pledged to work with labor unions and other left-leaning groups, he continued to warn against federal controls on drug prices, particularly in the Medicare drug benefit.
- Patient Harm Data to Remain on Medicare's Hospital Compare Site
- Quiet ORs Better for Patient Safety
- Tavenner Confirmed as CMS Administrator
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Building a Better Healthcare Board
- Hard-Nosed About Physician Teamwork
- Leapfrog Hospital Safety Scores 'Depressing'
- Case Study: Advance Care Conversations
- Healthcare Leaders Sound Off on Organized Labor
- CMS Releases Hospital Pricing Data